Double verification means analysing the same batch at two different points in the supply chain. The first layer certifies what the manufacturer produced. The second confirms that material received at destination corresponds to what was certified at origin.
What does double purity verification mean?
It means subjecting the same batch to two independent analyses at two different moments in its journey. The first occurs at origin, on material leaving the production plant. The second occurs at destination, on material arriving in the country where it will be distributed.
This is not repeating the same analysis for redundancy. Each layer answers a different question, and only the combination of both permits any statement about the specific vial a buyer receives.
What does each layer cover?
| Layer | Moment | Question answered | Limit |
|---|---|---|---|
| Origin | After synthesis, before shipping. | What did the manufacturer produce and at what purity? | Does not cover what happens after leaving the plant. |
| Destination | After import, before distribution. | Does received material correspond to what was certified? | Does not replace initial batch characterisation. |
The origin layer is what most suppliers present, when they present anything. It is a legitimate and necessary document. The point is that its scope ends at the factory door.
Why is a manufacturer COA not sufficient?
A manufacturer certificate describes a batch that existed in a plant, on a date, at a given purity. Between that moment and delivery to the final buyer lie several steps: packing, labelling, export, international transit, customs clearance and storage.
None of those steps is documented in the origin certificate. The claim the document supports is "this batch was produced at this purity", not "the vial in your hands belongs to this batch". The difference between those two claims is precisely the gap the second layer covers.
A physical consideration adds to this. Lyophilised peptides are stable under adequate conditions, but prolonged exposure to heat or humidity during transit can affect the material. An analysis at destination detects such degradation; a certificate issued months earlier does not.
Why does it matter that the second laboratory is independent?
Because verification performed by the distributor on its own product has the same conflict-of-interest problem as self-assessment. The value of the second layer depends on it being carried out by a third party with no stake in the result.
There is a relevant difference between an in-house laboratory and a contracted independent laboratory. In the first case, the seller also analyses. In the second, the seller pays for an analysis whose outcome it does not control. Precision in describing this relationship is part of the transparency being claimed.
Which questions reveal whether double verification exists?
Four concrete questions distinguish real double verification from a generic quality statement.
- ✓Identification: which laboratory performs each analysis and whether it can be contacted independently.
- ✓Timing: whether the second analysis is performed on already imported material or on a sample sent by the manufacturer.
- ✓Traceability: whether both documents reference the same batch number.
- ✓Rejection policy: what threshold is required and what happens to a batch that fails it.
The fourth question is usually the most revealing. A verification scheme that has never rejected a batch is not operating as a control, but as documentation.
The process applied at Vital Boost
The origin layer is the certificate issued by Janoshik Analytical, an independent analytical laboratory based in Czechia, on the produced batch, with purity by HPLC and identity by mass spectrometry.
The destination layer is an analysis performed by BT Labs, an independent contracted laboratory, on material arriving in Colombia. It is a contracted third party, not an in-house laboratory, precisely so the result does not depend on the distributor.
The scheme has been in continuous operation for over a year, applied to every batch sold. Process detail is on the purity verification page, which also describes the free review of third-party certificates of analysis.
References
- Mant CT, Chen Y, Yan Z, et al. HPLC analysis and purification of peptides. Methods Mol Biol. 2007;386:3-55. PMID: 18604941.
- Domon B, Aebersold R. Mass spectrometry and protein analysis. Science. 2006;312(5771):212-217. DOI: 10.1126/science.1124619.
- Manning MC, Chou DK, Murphy BM, et al. Stability of protein pharmaceuticals: an update. Pharm Res. 2010;27(4):544-575. DOI: 10.1007/s11095-009-0045-6.
